EGFR-independent activation of ERK1/2 mediates growth inhibition by a PTPase antagonizing K-vitamin analog
- 24 January 2002
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 190 (3) , 356-364
- https://doi.org/10.1002/jcp.10063
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Growth inhibition and protein tyrosine phosphorylation in MCF 7 breast cancer cells by a novel K vitaminJournal of Cellular Physiology, 2000
- Tyrosine Phosphorylation: Past, Present and FutureBiochemical Society Transactions, 1996
- Growth control and gene expression in a new hepatocellular carcinoma cell line, Hep40: Inhibitory actions of vitamin KJournal of Cellular Physiology, 1995
- Thioalkyl Derivatives of Vitamin K3 and Vitamin K3 Oxide Inhibit Growth of Hep3B and HepG2 CellsBioorganic Chemistry, 1995
- Protein kinases and phosphatases: The Yin and Yang of protein phosphorylation and signalingCell, 1995
- Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activationCell, 1995
- Cell movement elicited by epidermal growth factor receptor requires kinase and autophosphorylation but is separable from mitogenesisThe Journal of cell biology, 1994
- Vitamin K3 Inhibits Growth of Human Hepatoma HepG2 Cells by Decreasing Activities of Both p34cdc2 Kinase and PhosphataseBiochemical and Biophysical Research Communications, 1993
- Redox cycling and sulphydryl arylation; Their relative importance in the mechanism of quinone cytotoxicity to isolated hepatocytesChemico-Biological Interactions, 1988
- Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequencesNature, 1984